Non Invasive Blood Pressure Monitors Market
The Non-Invasive Blood Pressure Monitors Market is estimated to be valued at USD 34.61 Bn in 2026 and is expected to reach USD 55.32 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033. The market is witnessing steady transformation, mainly driven by the increasing prevalence of hypertension and cardiovascular diseases, rising adoption of home-based and ambulatory blood pressure monitoring, growing demand for automated and digital monitoring devices, and increasing integration of connected healthcare technologies.
Non-invasive blood pressure monitors are medical devices used to measure blood pressure without inserting a catheter into an artery. The market encompasses automated BP monitors, ambulatory BP monitors, sphygmomanometers, and BP transducers, along with digital, aneroid, and wearable technologies. These devices are increasingly used across hospitals, home care settings, ambulatory surgical centers, clinics, and diagnostic laboratories for routine cardiovascular assessment and long-term hypertension management.
Healthcare providers are increasingly emphasizing accurate and standardized blood pressure measurement, which is strengthening demand for clinically validated automated devices. At the same time, self-measured blood pressure monitoring is becoming increasingly integrated into hypertension-management programs. Automated devices allow patients to record blood pressure at home and share readings with healthcare professionals, supporting earlier intervention and continuous disease management.
Advancements in digital connectivity, remote patient monitoring, wearable technologies, data storage, and automated measurement are further expanding the application of non-invasive BP monitoring. Digital technology is expected to account for approximately 68.0% of the market in 2026, supported by automated measurement, digital displays, memory storage, connectivity, and integration with remote patient monitoring platforms.
Market Dynamics
The market is witnessing significant momentum owing to the rising global burden of hypertension and the increasing need for regular blood pressure monitoring. According to the World Health Organization, approximately 1.4 billion adults worldwide had hypertension in 2024, while only slightly more than one in five had their blood pressure under control. This large undiagnosed and inadequately controlled patient population is creating sustained demand for reliable blood pressure measurement across hospitals, primary care facilities, community programs, and home settings.
The growing adoption of self-measured blood pressure monitoring (SMBP) is another major factor driving market expansion. Automated non-invasive devices enable patients to measure blood pressure regularly outside conventional healthcare settings and transmit readings to physicians and care teams. In May 2026, the U.S. CDC highlighted SMBP with clinical support as an evidence-based intervention for improving hypertension control and estimated that expanded SMBP programs could reduce heart attacks by 4.9% and strokes by 3.8%.
Increasing emphasis on clinically validated and accurate BP measurement is also supporting device deployment. Healthcare systems are placing greater importance on standardized measurement protocols because inaccurate readings can result in incorrect diagnosis and treatment decisions. The WHO Global Report on Hypertension 2025 identified limited access to validated blood pressure measurement devices as an important obstacle to effective hypertension diagnosis and management.
The expansion of connected healthcare and remote patient monitoring is creating additional growth opportunities. Connected blood pressure cuffs and digital monitoring platforms allow readings to be transmitted directly to healthcare providers, improving longitudinal disease management. Medicare coverage for eligible remote patient monitoring technologies, including connected blood pressure cuffs, is strengthening the commercial environment for digitally enabled NIBP devices.
Innovation in cuffless and wearable BP monitoring technologies is also reshaping the competitive landscape. Smartwatches, rings, patches, and fingertip monitoring systems are expanding the possibilities for continuous and convenient BP measurement. However, accuracy validation remains an important challenge, with regulatory authorities and professional associations placing increasing emphasis on real-world clinical performance and standardized validation.
Hospitals remain an important demand center because of high-frequency BP monitoring across emergency departments, operating rooms, intensive care units, inpatient wards, cardiology departments, and perioperative settings. Hospitals are anticipated to account for approximately 45.0% of the end-user market in 2026.
North America is expected to remain the leading regional market, accounting for approximately 38.5% of global market share in 2026, supported by strong penetration of automated BP monitors, extensive home and ambulatory monitoring, established healthcare infrastructure, favorable reimbursement for connected monitoring, and increasing emphasis on clinically validated devices. Asia Pacific, meanwhile, is expected to be the fastest-growing region during 2026–2033, supported by large-scale hypertension screening and treatment programs, expanding primary healthcare infrastructure, and increasing deployment of digital monitoring systems.
Key Features of the Study
Market Segmentation
Market Segmentation
すべてのレポートを無料でカスタマイズ可能です。単独セクションの購入や国別レポートも含まれます。
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
